BACKGROUND: The basis for increased susceptibility of patients with atopic dermatitis (AD) to develop disseminated viral skin infections such as eczema herpeticum (AD with a history of eczema herpeticum, ADEH(+)) is poorly understood. OBJECTIVE: We sought to determine whether subjects with AD prone to disseminated viral skin infections have defects in their IFN responses. METHODS: GeneChip profiling was used to identify differences in gene expression of PBMCs from patients with ADEH(+) compared with patients with AD without a history of eczema herpeticum (ADEH(-)) and nonatopic controls. Key differences in protein expression were verified by enzyme-linked immunosorbent spot assay and/or ELISA. Clinical relevance was further demonstrated by a mouse model of disseminated viral skin infection and genetic association analysis for genetic variants in IFNG and IFNGR1 and ADEH among 435 cases and controls. RESULTS: We demonstrate by global gene expression analysis selective transcriptomic changes within the IFN superfamily of PBMCs from subjects with ADEH(+) reflecting low IFN-γ and IFN-γ receptor gene expression. IFN-γ protein production was also significantly lower in patients with ADEH(+) (n = 24) compared with patients with ADEH(-) (n = 20) and nonatopic controls (n = 20). IFN-γ receptor knockout mice developed disseminated viral skin infection after epicutaneous challenge with vaccinia virus. Genetic variants in IFNG and IFNGR1 single nucleotide polymorphisms (SNPs) were significantly associated with ADEH (112 cases, 166 controls) and IFN-γ production: a 2-SNP (A-G) IFNGR1 haplotype (rs10457655 and rs7749390) showed the strongest association with a reduced risk of ADEH+ (13.2% ADEH(+) vs 25.5% ADEH(-); P = .00057). CONCLUSION: Patients with ADEH(+) have reduced IFN-γ production, and IFNG and IFNGR1 SNPs are significantly associated with ADEH(+) and may contribute to an impaired immune response to herpes simplex virus.
BACKGROUND: The basis for increased susceptibility of patients with atopic dermatitis (AD) to develop disseminated viral skin infections such as eczema herpeticum (AD with a history of eczema herpeticum, ADEH(+)) is poorly understood. OBJECTIVE: We sought to determine whether subjects with AD prone to disseminated viral skin infections have defects in their IFN responses. METHODS: GeneChip profiling was used to identify differences in gene expression of PBMCs from patients with ADEH(+) compared with patients with AD without a history of eczema herpeticum (ADEH(-)) and nonatopic controls. Key differences in protein expression were verified by enzyme-linked immunosorbent spot assay and/or ELISA. Clinical relevance was further demonstrated by a mouse model of disseminated viral skin infection and genetic association analysis for genetic variants in IFNG and IFNGR1 and ADEH among 435 cases and controls. RESULTS: We demonstrate by global gene expression analysis selective transcriptomic changes within the IFN superfamily of PBMCs from subjects with ADEH(+) reflecting low IFN-γ and IFN-γ receptor gene expression. IFN-γ protein production was also significantly lower in patients with ADEH(+) (n = 24) compared with patients with ADEH(-) (n = 20) and nonatopic controls (n = 20). IFN-γ receptor knockout mice developed disseminated viral skin infection after epicutaneous challenge with vaccinia virus. Genetic variants in IFNG and IFNGR1 single nucleotide polymorphisms (SNPs) were significantly associated with ADEH (112 cases, 166 controls) and IFN-γ production: a 2-SNP (A-G) IFNGR1 haplotype (rs10457655 and rs7749390) showed the strongest association with a reduced risk of ADEH+ (13.2% ADEH(+) vs 25.5% ADEH(-); P = .00057). CONCLUSION: Patients with ADEH(+) have reduced IFN-γ production, and IFNG and IFNGR1 SNPs are significantly associated with ADEH(+) and may contribute to an impaired immune response to herpes simplex virus.
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: Joseph A Odhiambo; Hywel C Williams; Tadd O Clayton; Colin F Robertson; M Innes Asher Journal: J Allergy Clin Immunol Date: 2009-12 Impact factor: 10.793
Authors: Astanand Jugessur; Fedik Rahimov; Rolv T Lie; Allen J Wilcox; Håkon K Gjessing; Roy M Nilsen; Truc Trung Nguyen; Jeffrey C Murray Journal: Genet Epidemiol Date: 2008-07 Impact factor: 2.135
Authors: Michael D Howell; James F Jones; Kevin O Kisich; Joanne E Streib; Richard L Gallo; Donald Y M Leung Journal: J Immunol Date: 2004-02-01 Impact factor: 5.422
Authors: Dmitry N Grigoryev; Michael D Howell; Tonya N Watkins; Yu-Chi Chen; Chris Cheadle; Mark Boguniewicz; Kathleen C Barnes; Donald Y M Leung Journal: J Allergy Clin Immunol Date: 2010-01 Impact factor: 10.793
Authors: Surabhi Vora; Inger Damon; Vincent Fulginiti; Stephen G Weber; Madelyn Kahana; Sarah L Stein; Susan I Gerber; Sylvia Garcia-Houchins; Edith Lederman; Dennis Hruby; Limone Collins; Dorothy Scott; Kenneth Thompson; John V Barson; Russell Regnery; Christine Hughes; Robert S Daum; Yu Li; Hui Zhao; Scott Smith; Zach Braden; Kevin Karem; Victoria Olson; Whitni Davidson; Giliane Trindade; Tove Bolken; Robert Jordan; Debbie Tien; John Marcinak Journal: Clin Infect Dis Date: 2008-05-15 Impact factor: 20.999
Authors: Lianghua Bin; Michael G Edwards; Ryan Heiser; Joanne E Streib; Brittany Richers; Clifton F Hall; Donald Y M Leung Journal: J Allergy Clin Immunol Date: 2014-08-23 Impact factor: 10.793
Authors: Michael D Howell; Peisong Gao; Byung Eui Kim; Leighann J Lesley; Joanne E Streib; Patricia A Taylor; Daniel J Zaccaro; Mark Boguniewicz; Lisa A Beck; Jon M Hanifin; Lynda C Schneider; Tissa R Hata; Richard L Gallo; Mark H Kaplan; Kathleen C Barnes; Donald Y M Leung Journal: J Allergy Clin Immunol Date: 2011-07-18 Impact factor: 10.793
Authors: Hyo Jin Kwon; Duk Won Bang; Eun Na Kim; Chung-Il Wi; Barbara P Yawn; Peter C Wollan; Brian D Lahr; Euijung Ryu; Young J Juhn Journal: J Allergy Clin Immunol Date: 2015-12-28 Impact factor: 10.793